🇺🇸
United States · US · US:16729-267_1fbda3cb-1ba1-490d-e063-6294a90a6777
DOCETAXEL
In shortageOrange BookUNIISPLATC L01CD02
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerAccord Healthcare Inc.
CountryUS (United States)
ATC codeL01CD02
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 3
- ndc1116729267631 VIAL, MULTI-DOSE in 1 CARTON (16729-267-63) / 1 mL in 1 VIAL, MULTI-DOSE
- ndc1116729267641 VIAL, MULTI-DOSE in 1 CARTON (16729-267-64) / 4 mL in 1 VIAL, MULTI-DOSE
- ndc1116729267651 VIAL, MULTI-DOSE in 1 CARTON (16729-267-65) / 8 mL in 1 VIAL, MULTI-DOSE
Annotations
UNII (FDA Substance ID)
699121PHCA
DOCETAXEL ANHYDROUS
RxCUI 1299922
Orange Book
N201195
APAPAP
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Docetaxel Injection
Raw payload (JSON)
{
"unii": {
"unii": "699121PHCA",
"rxcui": "1299922",
"inchikey": "ZDZOTLJHXYCWBA-VCVYQWHSSA-N",
"display_name": "DOCETAXEL ANHYDROUS",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"81686d37-a13f-46e2-b439-a84eb1433634": {
"match": "brand_token",
"title": "DOCETAXEL INJECTION [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.]",
"spl_version": "2",
"published_date": "2026-05-13"
}
},
"productid": "16729-267_1fbda3cb-1ba1-490d-e063-6294a90a6777",
"productndc": "16729-267",
"dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
"orange_book": {
"appl_no": "201195",
"products": [
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "20MG/0.5ML (40MG/ML)",
"product_no": "001",
"approval_date": "Jun 8, 2011"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "80MG/2ML (40MG/ML)",
"product_no": "002",
"approval_date": "Jun 8, 2011"
},
{
"rs": false,
"rld": true,
"te_code": "AP",
"strength": "20MG/ML (20MG/ML)",
"product_no": "003",
"approval_date": "Apr 20, 2012"
},
{
"rs": false,
"rld": true,
"te_code": "AP",
"strength": "80MG/4ML (20MG/ML)",
"product_no": "004",
"approval_date": "Apr 20, 2012"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "160MG/8ML (20MG/ML)",
"product_no": "005",
"approval_date": "Apr 20, 2012"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "DOCETAXEL ANHYDROUS",
"shortage_reason": "Docetaxel Injection",
"shortage_status": "current",
"proprietary_name": "DOCETAXEL",
"active_ingred_unit": "mg/mL",
"application_number": "NDA201195",
"marketing_category": "NDA",
"nonproprietary_name": "docetaxel",
"start_marketing_date": "20130530",
"active_numerator_strength": "20"
}Related drugs
Other records sharing ATC code L01CD02.
- BEBaglycacon 10 mg/mlSandoz
- BEBaglycacon 10 mg/mlSandoz
- BEBaglycacon 10 mg/mlSandoz
- 🇺🇸BEIZRAYZydus Pharmaceuticals USA Inc.
- 🇺🇸BEIZRAYZhuhai Beihai Biotech Co., Ltd.
- 🇺🇸BEIZRAYZydus Pharmaceuticals USA Inc.
- 🇺🇸BEIZRAYZhuhai Beihai Biotech Co., Ltd.
- NLDemotaxel Mono 20 mg/ml, concentraat voor oplossing voor infusieDemo S.A. Pharmaceutical Industry
Access this data programmatically
Query DOCETAXEL and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.